All News

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

After switching to 1 of 2 adalimumab biosimilars, patients with inflammatory bowel disease (IBD) experienced comparable clinical outcomes to the reference product after 6 months, according to a recent study.

Joe Zein, MD, PhD, from Cleveland Clinic, explains factors apart from sex and age that can have an impact on a patient's asthma.

Confirmed disability progression is often used as a study endpoint to predict progression, but a new report says its predictive value may be overblown.

Matthew Reynolds, PhD, vice president of real-world evidence at IQVIA, discusses findings of a recent paper with the National Pharmaceutical Council on how COVID-19 affected real-world data and research, as well as implications for future studies.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

The new analysis suggests that dementia screenings might also include kidney function estimation.

As a validated health-related quality of life (HRQOL) measurement is not widely used among patients receiving this type of treatment, trials take advantage of traditional HRQOL tools.

Results of a US claims database show erenumab is associated with reduced acute medication use and health care resource utilization.

Technological innovation is helping to reinvent the traditional health economics and outcomes research (HEOR) field as traditional and new players partner to leverage data sources.

Stakeholders identify the value elements of comprehensive genomic profiling (CGP) they find most important, as well as options for innovative contracts.

People who suffer from shift work sleep disorder face the highest risk of a car crash, although sleep apnea and insomnia also heighten a person’s risk.

The technique uses optical coherence tomography angiography to assess the motion of blood flow, instead of static images.

As the cost of therapies increases, US health plans are utilizing tools like step therapy, to ensure patients try cheaper alternatives first, and value assessment frameworks, to assist with the decision-making process.

Mark Trusheim, MS, BS, strategic director at the NEW Drug Development ParadIGmS program and visiting scientist at Massachusetts Institute of Technology, explains factors involved when considering whether a therapy would be suitable for performance-based contracting.

It is already known that dual-eligible older adults are at an increased risk for death in the year following a stay in the intensive care unit (ICU), but it previously wasn't known whether dual-eligible status is linked with functional decline after an ICU stay.

Here are some of the latest developments in multiple sclerosis (MS) from our sister publication, NeurologyLive®.

When drug developers were forced to conduct cardiovascular outcomes trials for SGLT2 inhibitors, they found a surprise: the drugs created for type 2 diabetes (T2D) had strong benefits for heart failure. And the same has proven true in sotagliflozin.

According to researchers, the findings suggest that receiving ibrutinib improves the activity of anti-CD19-CAR T cells.

With more than 3000 gene therapies in development, payers will have to grapple with the challenges of paying for these innovative but expensive therapies.

Patients with refractory or unexplained chronic cough are concerned about how they appear to others, and it takes them many years to get diagnosed, according to posters presented at the American Thoracic Society 2021 International Conference.

Sonia T. Oskouei, PharmD, BCMAS, DPLA, from Cardinal Health, highlights the important role that pharmacists can play in promoting uptake and expanding education efforts for biosimilars.

Stephanie Lovinsky-Desir, MD, MS, describes her research on the impact of environmental factors on respiratory health among children.

Amy Abernethy, MD, PhD, a hematologist/oncologist and palliative medicine physician, and former Principal Deputy Commissioner of the FDA, discusses new collaborations in the health economics and outcomes research (HEOR) landscape.

Children with severe atopic dermatitis, in particular, were less likely than a control group to complete education at all levels, from basic compulsory education to postgraduate education.

New guidelines recommend Americans get screened earlier for colon cancer; Johns Hopkins University will send mental health providers on security calls; Tennessee's governor signs bill limiting health care for transgender youth.

Farrah Kheradmand, MD, explains the effects of vaping duration on lung function.